Page 89 - Read Online
P. 89

Choi et al. Cancer Drug Resist. 2026;9:12                                        Page 15 of 20






               Among various modulation modalities, US is uniquely capable of delivering focused energy to highly
               localized regions within the brain. This feature is advantageous for minimizing off-target toxicity in
               surrounding tissues - an especially critical consideration in oncology. However, most glymphatic modulation
               studies to date have been designed to influence broad cortical or subcortical regions simultaneously, and thus
               the potential benefit of localized glymphatic modulation remains underexplored. This raises an important
               question: which brain pathologies, beyond tumors, exhibit spatially localized glymphatic impairment, and to
               what extent can localized modulation improve therapeutic outcomes? Addressing this question may broaden
               the clinical relevance of US-based glymphatic modulation to conditions such as traumatic brain injury,
               stroke, or focal epileptic lesions, although these applications have not yet been systematically evaluated to the
               best of our knowledge.


               At the same time, several key challenges remain for the effective translation of US-based glymphatic
               modulation. These include the lack of standardized US parameters across studies, incomplete understanding
               of dose-response relationships between acoustic exposure and glymphatic transport, and limited ability to
               noninvasively and quantitatively monitor glymphatic modulation in real-time. In transcranial applications,
               skull-induced acoustic attenuation, phase aberration, and focal distortion further complicate accurate energy
               delivery, potentially limiting penetration depth and spatial precision of US-based glymphatic modulation. In
               addition, disease-specific variability in vascular integrity, interstitial pressure, and perivascular
               architecture–together with inter-individual differences in skull thickness and geometry–may further
               complicate parameter optimization, particularly in heterogeneous tumor environments. Addressing these
               technical and biological challenges will be critical for advancing US-based glymphatic modulation toward
               reliable and reproducible clinical applications.


               Observation of the glymphatic flow alterations has primarily relied on MRI and optical imaging, both of
               which enable dynamic visualization of contrast transport at different spatial scales. Contrast-enhanced MRI
               provides whole-brain, macroscale characterization of glymphatic pathways in both small animals and
               humans, whereas optical imaging allows microscale resolution in superficial regions of rodent brains through
               optical windows. An emerging complementary approach is photoacoustic imaging (PAI), which detects
               optically absorptive chromophores with ultrasonic resolution [67,68] . Because PAI can be deployed across a
               wide range of imaging depths - from photoacoustic microscopy to photoacoustic tomography - it effectively
               bridges the resolution-depth gap between pure optical imaging and tomographic modalities such as MRI or
               PET [69-71] . Although its application to glymphatic imaging is still recent , PAI’s scalability and compatibility
                                                                          [72]
               with US-based modulation systems suggest that it could become a valuable tool for monitoring
               US-augmented glymphatic flow [73-75] . Moreover, functional vessel-imaging methods such as ultrafast US
               Doppler could help identify pulsatile vascular segments and clarify their mechanistic relationship with
               glymphatic flow [76-78] .


               Accurate assessment of glymphatic function, however, requires careful attention to experimental factors that
               directly influence lymphatic and glymphatic dynamics . Bouta et al. systematically evaluated how key
                                                               [79]
               physical variables - animal posture, contrast agent injection volume, and mechanical tissue support - alter
               lymphatic contraction physiology . Rather than treating these variables as procedural details, they should be
                                           [80]
               recognized as critical control parameters that shape the reproducibility and interpretability of lymphatic
               imaging studies. First, mouse posture relative to gravity significantly affected lymphatic contraction
               frequency: upright positioning preserved normal contraction rates, whereas the supine position markedly
               reduced them, despite unchanged ejection fraction (EF). This finding implies that gravitational forces impose
               resistance that alters lymphatic pumping rhythms, a consideration especially relevant when imaging contrast




                                                           82
   84   85   86   87   88   89   90   91   92   93   94